IRLAB Therapeutics AB
STO:IRLAB A

Watchlist Manager
IRLAB Therapeutics AB Logo
IRLAB Therapeutics AB
STO:IRLAB A
Watchlist
Price: 12.6 SEK -1.95%
Market Cap: 652.5m SEK
Have any thoughts about
IRLAB Therapeutics AB?
Write Note

IRLAB Therapeutics AB
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

IRLAB Therapeutics AB
Net Change in Cash Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
MOB
I
FLERIE

Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
IRLAB Therapeutics AB
STO:IRLAB A
Net Change in Cash
-kr141.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Net Change in Cash
-kr68.9m
CAGR 3-Years
55%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Net Change in Cash
kr1.9B
CAGR 3-Years
112%
CAGR 5-Years
87%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Net Change in Cash
-kr27.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Net Change in Cash
-kr65m
CAGR 3-Years
58%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Net Change in Cash
kr456.7m
CAGR 3-Years
4%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is IRLAB Therapeutics AB's Net Change in Cash?
Net Change in Cash
-141.5m SEK

Based on the financial report for Dec 31, 2023, IRLAB Therapeutics AB's Net Change in Cash amounts to -141.5m SEK.

What is IRLAB Therapeutics AB's Net Change in Cash growth rate?
Net Change in Cash CAGR 1Y
5%

Over the last year, the Net Change in Cash growth was 5%.

Back to Top